Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation

Blood (2025) 146 (Supplement 1): 3601.

https://doi.org/10.1182/blood-2025-3601

Published: 2025

Journal Articles

Apolipoproteins from the microenvironment promote aggressive myeloid leukemia progression

Christina Kaszuba, Sonali Sharma, Benjamin Rodems, Edgardo Franco, Cameron Baker, Francisco Chaves, Yi Zhang, Philip Rock, Richard Burack, John Ashton, Jane Liesveld, Jeevisha Bajaj

Blood (2025) 146 (Supplement 1): 3186.

https://doi.org/10.1182/blood-2025-3186

Published: 2025

Journal Articles

Relapsed diffuse large B-cell lymphoma is shaped by molecular subtypes and genomic alterations

Blood (2025) 146 (Supplement 1): 349.

https://doi.org/10.1182/blood-2025-349

Published: 2025

Journal Articles

FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting

Blood (2025) 146 (Supplement 1): 5354.

https://doi.org/10.1182/blood-2025-5354

Published: 2025

Journal Articles

Dissecting the biology of hairy cell leukemia variant: Insights from whole exome and RNA sequencing

Antonia-Zoe Kouroutzidou, Anastasia Anastasiadou, Nikolaos Pechlivanis, Marina Gerousi, Maria Fitopoulou, Philip Rock, Clive Zent, Charles Chu, Fotis Psomopoulos, Anastasia Chatzidimitriou, Richard Burack, Kostas Stamatopoulos, Stamatia Laidou

Blood (2025) 146 (Supplement 1): 5306.

https://doi.org/10.1182/blood-2025-5306

Published: 2025

Journal Articles

Immunoglobulin variable gene diversity reflects distinct metabolic/signaling states and impacts measurable residual disease monitoring and clinical outcome in B cell acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 333.

https://doi.org/10.1182/blood-2025-333

Published: 2025

Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood (2024) 144 (19): 2063–2066.

https://doi.org/10.1182/blood.2024025681

Published: 2024

Includes: Supplemental data

Journal Articles

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Blood (2024) 144 (Supplement 1): 3007.

https://doi.org/10.1182/blood-2024-202088

Published: 2024

Journal Articles

Flow Cytometry Evaluation of T-Cell Receptor Constant Beta Chain-1 (TRBC1) Expression and Characterization of T-Cell Clones of Uncertain Significance

Giby V. George, Tia LaBarge, W. Richard Burack, Siba El Hussein, Danielle S Wallace, Chauncey R. Syposs

Blood (2024) 144 (Supplement 1): 6218.

https://doi.org/10.1182/blood-2024-204156

Published: 2024

Journal Articles

Distinct Signaling Profiles in Primary Splenic Small B-Cell Lymphomas

Marina Gerousi, Maria Fitopoulou, Malama Galanou, Philip Rock, Georgios Karakatsoulis, Anastasia Anastasiadou, Maria Karipidou, Anastasia Iatrou, Efthalia Karamanli, Nikolaos Vastarouchas, Paolo Ghia, Charles C Chu, Clive S Zent, Richard Burack, Anastasia Chatzidimitriou, Kostas Stamatopoulos

Blood (2024) 144 (Supplement 1): 3002.

https://doi.org/10.1182/blood-2024-207057

Published: 2024

Journal Articles

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

Carol Fries Simpson, Lik Wee Lee, Hongyue Wang, Diana G. Adlowitz, Philip Rock, Brent L. Wood, Rachel E. Rau, Kara L. Davis, Anne Angiolillo, Meenakshi Devidas, David T. Teachey, Karen R Rabin, Birte Wistinghausen, Donald Barkauskas, Robert J. Hayashi, Richard Burack, Carl E Allen, Michelle L. Hermiston, Ilan R. Kirsch

Blood (2024) 144 (Supplement 1): 2838.

https://doi.org/10.1182/blood-2024-201634

Published: 2024

Journal Articles

Comparative Analysis of T Cell Profiles in Splenic Small B-Cell Malignancies

Elisavet Vlachonikola, Antonios Mingos, Philip Rock, Glykeria Gkoliou, Marina Gerousi, Maria Fitopoulou, Nikolaos Pechlivanis, Maria Karipidou, Anastasia Iatrou, Malama Galanou, Efthalia Karamanli, Nikolaos Vastarouchas, Charles C Chu, Clive S Zent, Richard Burack, Anastasia Chatzidimitriou, Kostas Stamatopoulos

Blood (2024) 144 (Supplement 1): 3000.

https://doi.org/10.1182/blood-2024-209511

Published: 2024

Journal Articles

Outcomes in Early Relapse of Follicular Lymphoma Versus Early Histologic Transformation Following Firstline Immunochemotherapy in Follicular Lymphoma

Blood (2024) 144 (Supplement 1): 1652.

https://doi.org/10.1182/blood-2024-201078

Published: 2024

Journal Articles

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Blood (2024) 144 (Supplement 1): 1629.

https://doi.org/10.1182/blood-2024-194681

Published: 2024

Journal Articles

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Blood (2023) 142 (Supplement 1): 174.

https://doi.org/10.1182/blood-2023-189835

Published: 2023

Journal Articles

Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study

Blood (2023) 142 (Supplement 1): 3708.

https://doi.org/10.1182/blood-2023-179303

Published: 2023

Journal Articles

Localization of DC-SIGN Expressing Cells in Follicular Lymphoma

Dingani Nkosi, Philip J Rock, Rachel C Gargan, Richard Burack, Yi Zhang

Blood (2023) 142 (Supplement 1): 6122.

https://doi.org/10.1182/blood-2023-186214

Published: 2023

Journal Articles

Enrichment in Metabolic Pathway Activation Corresponds to Immunoglobulin Gene Diversity across B Cell Developmental Stages in B-Lymphoblastic Leukemia

Carol Fries Simpson, Yuxuan Liu, Lucille Stuani, Astraea Jager, Cameron Baker, Diana G. Adlowitz, Philip J Rock, Richard Burack, Kara L. Davis

Blood (2023) 142 (Supplement 1): 2972.

https://doi.org/10.1182/blood-2023-189313

Published: 2023

Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Blood (2023) 142 (Supplement 1): 1657.

https://doi.org/10.1182/blood-2023-186684

Published: 2023

Journal Articles

Patterns of Care and Prognostic Modeling Following Follicular Lymphoma Transformation to Aggressive B-Cell Lymphoma: An Analysis from the LEO Consortium

Jonathan R Day, Melissa C. Larson, Carla Casulo, Urshila Durani, Yucai Wang, Dai Chihara, Loretta J. Nastoupil, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Jason T. Romancik, Amy Ayers, Richard Burack, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Brian K. Link

Blood (2023) 142 (Supplement 1): 3111.

https://doi.org/10.1182/blood-2023-179650

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation

Apolipoproteins from the microenvironment promote aggressive myeloid leukemia progression

Relapsed diffuse large B-cell lymphoma is shaped by molecular subtypes and genomic alterations

FLP-R: A clinical prediction model for follicular lymphoma Prognosis in the Relapsed/refractory setting

Dissecting the biology of hairy cell leukemia variant: Insights from whole exome and RNA sequencing

Immunoglobulin variable gene diversity reflects distinct metabolic/signaling states and impacts measurable residual disease monitoring and clinical outcome in B cell acute lymphoblastic leukemia

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Frontline R-CHOP and BR Have Similar Outcomes By SUV max in Follicular Lymphoma

Flow Cytometry Evaluation of T-Cell Receptor Constant Beta Chain-1 (TRBC1) Expression and Characterization of T-Cell Clones of Uncertain Significance

Distinct Signaling Profiles in Primary Splenic Small B-Cell Lymphomas

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

Comparative Analysis of T Cell Profiles in Splenic Small B-Cell Malignancies

Outcomes in Early Relapse of Follicular Lymphoma Versus Early Histologic Transformation Following Firstline Immunochemotherapy in Follicular Lymphoma

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma

Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study

Localization of DC-SIGN Expressing Cells in Follicular Lymphoma

Enrichment in Metabolic Pathway Activation Corresponds to Immunoglobulin Gene Diversity across B Cell Developmental Stages in B-Lymphoblastic Leukemia

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Patterns of Care and Prognostic Modeling Following Follicular Lymphoma Transformation to Aggressive B-Cell Lymphoma: An Analysis from the LEO Consortium

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only